Sun Pharmaceutical Industries Limited has informed the Exchange about Schedule of meet
SUNPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sun Pharmaceutical Industries has disclosed its schedule of upcoming analyst and institutional investor meetings for early June 2026. The company will participate in three major investor conferences: BofA India Conference (June 1), Morgan Stanley's India Investment Forum (June 2), and Citi India Conference (June 4). All meetings will be held physically in Mumbai and include both group and one-on-one formats. The company has explicitly stated that no Unpublished Price Sensitive Information will be disclosed at these meetings. The schedule is subject to change due to exigencies on either side.
This is a routine regulatory filing under SEBI's disclosure requirements. The disclosure indicates continued engagement with institutional investors, which is standard for a large-cap pharmaceutical company. The explicit no-UPSI statement reduces speculation risk. No material impact on stock price expected from this filing.